Nightingale Health’s strategic collaboration with UK Biobank progresses: Biomarker results of additional 200,000 blood samples soon available to researchers globally
Press release, 6 June 2023 at 9:00 a.m. (EEST) Nightingale Health Plc (“Nightingale Health”), a technology company promoting preventative health with its proprietary health risk detection platform, announced today that the biomarker results from additional 200,000 blood samples from UK Biobank are being made accessible to researchers. This large-scale release of biomarker results further increases the use of Nightingale Health’s technology in global medical research. Currently, UK Biobank has over 30,000 registered researchers from over 90 countries. The biomarker results will be